Literature DB >> 6606534

Amiodarone-induced hypersensitivity pneumonitis. Evidence of an immunological cell-mediated mechanism.

G M Akoun, S Gauthier-Rahman, B J Milleron, J Y Perrot, C M Mayaud.   

Abstract

Interstitial pneumonitis developed in a patient who had received a cumulative dose of 985 g of amiodarone in nine years. No other cause for pneumonitis was found. The following findings favor an immunologic mechanism of hypersensitivity due to amiodarone: positive skin and basophil degranulation tests with amiodarone; lymphocytosis and inverted ratio of helper/suppressor T lymphocytes in bronchoalveolar lavage fluid; secretion of leukocyte inhibitory factor, as shown by the inhibition of migration of peripheral blood leukocytes; and positive lymphoblastic transformation in the presence of amiodarone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6606534     DOI: 10.1378/chest.85.1.133

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

1.  Amiodarone pulmonary toxicity.

Authors:  J L Retz; W J Martin
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

2.  Diagnosis by bronchoalveolar lavage of cause of pulmonary infiltrates in haematological malignancies.

Authors:  G M Akoun; B J Milleron; C M Mayaud
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-25

3.  Aripiprazole-induced hypersensitivity pneumonitis.

Authors:  Kulothungan Gunasekaran; Swetha Murthi; Jeffrey Jennings; Nazir Lone
Journal:  BMJ Case Rep       Date:  2017-05-09

4.  Susceptibility to amiodarone-induced pulmonary toxicity: relationship to the uptake of amiodarone by isolated lung cells.

Authors:  B D Wilson; M L Lippmann
Journal:  Lung       Date:  1996       Impact factor: 2.584

5.  Amiodarone-induced pulmonary toxicity in the rat.

Authors:  B D Wilson; A J Jaworski; M E Donner; M L Lippmann
Journal:  Lung       Date:  1989       Impact factor: 2.584

6.  Amiodarone pulmonary toxicity: functional and ultrastructural evaluation.

Authors:  F L Liu; R D Cohen; E Downar; J W Butany; J D Edelson; A S Rebuck
Journal:  Thorax       Date:  1986-02       Impact factor: 9.139

Review 7.  Amiodarone: review of pulmonary effects and toxicity.

Authors:  Spyros A Papiris; Christina Triantafillidou; Likurgos Kolilekas; Despoina Markoulaki; Effrosyni D Manali
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

8.  Pulmonary complications after long term amiodarone treatment.

Authors:  J Roca; M Heras; R Rodriguez-Roisin; J Magriñà; A Xaubet; G Sanz
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

9.  Amiodarone-induced lung toxicity. In vitro evidence for the direct toxicity of the drug.

Authors:  W J Martin; D M Howard
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

10.  Modulation of both activator protein-1 and nuclear factor-kappa B signal transduction of human T cells by amiodarone.

Authors:  Shu-Meng Cheng; Wei-Hsiang Lin; Chin-Sheng Lin; Ling-Jun Ho; Tsung-Neng Tsai; Chun-Hsien Wu; Jenn-Haung Lai; Shih-Ping Yang
Journal:  Exp Biol Med (Maywood)       Date:  2014-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.